Tradestie Institutional Equity Comparison Engine

AVDL vs PAHC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PAHC Overall Edge

PAHC Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Phibro Animal Health Corporation Class A (PAHC) driven by superior Valuation, Growth & Margin, Options & Structure while AVDL counters with relative strength in Momentum & Technical. Fundamentally, AVDL trades at 28.8x Forward P/E with 2.5% operating margin (+54.9% YoY revenue) versus PAHC at 10.0x Forward P/E and 12.7% operating margin (+6.3% YoY). In options structure, AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PAHC sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PAHC
AVDL 28.8x vs PAHC 10.0x Fwd P/E
Growth & Margin Winner PAHC
Op Margin 2.5% vs 12.7% ยท YoY +54.9% vs +6.3%
Momentum & Technical Winner AVDL
1Y +138.1% vs -19.6% ยท 52W Pos 89% vs 16%
Options & Structure Winner PAHC
UNCLASSIFIED (<1st %ile IV) vs CONSOLIDATION (9th %ile IV)
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
PAHC NASDAQ
Phibro Animal Health Corporation Class A
Pharmaceutical Preparations
$33.29
-2.32% 1D
Market Cap $1.4B
1M Return -16.38%
1Y Return -19.55%
Forward P/E 10.0x
Unified AI Score
65.9 / 100 BUY
Tech 70.0 Fund 65.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AVDL +138.06% PAHC -19.55% Spread: +30.82 pp (PAHC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AVDL TTM Op. Margin: 2.5% PAHC TTM Op. Margin: 12.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVDL vs PAHC. Trailing 12-month operating profitability (AVDL 2.5% vs PAHC 12.7%) and valuation multiples (AVDL 28.8x vs PAHC 10.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AVDL (4) vs PAHC (6)
Institutional Metric AVDL PAHC Criterion Row Winner
Market Capitalization Scale $2.1B $1.4B Larger Scale AVDL
Trailing P/E Ratio Valuation 16.8x 14.2x Lower Multiple PAHC
Forward P/E Ratio Valuation 28.8x 10.0x Lower Multiple PAHC
Revenue Growth (YoY) Growth +54.9% +6.3% Higher Growth AVDL
Operating Margin (TTM) Profitability 2.5% 12.7% Higher Margin PAHC
Net Profit Margin Profitability -0.1% 6.7% Higher Margin PAHC
Return on Equity (ROE) Capital Efficiency -0.3% 28.2% Higher ROE PAHC
52-Week Range Position Momentum 89% ($6โ€“$24) 16% ($28โ€“$60) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 0.14ฮฒ ยท 2% Vol 1.04ฮฒ ยท 55% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 62.9 / 100 (BUY) 65.9 / 100 (BUY) Higher Composite PAHC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AVDL vs PAHC Buy Guide
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PAHC CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live PAHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AVDL nor PAHC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.